IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance

키워드

참고문헌 (106)

1. Dinarello CA, "Immunological and inflammatory functions of the interleukin-1 family", Annu Rev Immunol, 27, pp.519~550 (2009)
2. Dinarello CA, "Overview of the IL-1 family in innate inflammation and acquired immunity", Immunol Rev, 281, pp.8~27 (2018)
3. Garlanda C, "The interleukin-1 family : back to the future", Immunity, 39, pp.1003~1018 (2013)
4. Dinarello CA, "The IL-1 family of cytokines and receptors in rheumatic diseases", Nat Rev Rheumatol, 15, pp.612~632 (2019)
5. Kim B, "The interleukin-1α precursor is biologically active and is likely a key alarmin in the IL-1 family of cytokines", Front Immunol, 4, pp.391~ (2013)
6. Lee WW, "Regulating human Th17 cells via differential expression of IL-1 receptor", Blood, 115, pp.530~540 (2010)
7. Kim DH, "Induction of the IL-1RII decoy receptor by NFAT", FOXP3 blocks IL-1β-dependent response of Th17 cells, 2021, pp.10, e61841~
8. Sims JE, "The IL-1 family : regulators of immunity", Nat Rev Immunol, 10, pp.89~102 (2010)
9. Korherr C, "A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling", Eur J Immunol, 27, pp.262~267 (1997)
10. Cullinan EB, "IL-1 receptor accessory protein is an essential component of the IL-1 receptor", J Immunol, 161, pp.5614~5620 (1998)
11. Boraschi D, "The interleukin-1 receptor family", Semin Immunol, 25, pp.394~407 (2013)
12. Kaneko N, "The role of interleukin-1 in general pathology", Inflamm Regen, 39, pp.12~ (2019)
13. Liu X, "Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities", Immunity, 50, pp.317~333 (2019)
14. Ching S, "IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system", Brain Behav Immun, 19, pp.127~137 (2005)
15. Sims JE, "cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily", Science, 241, pp.585~589 (1988)
16. Kim DH, "Induction of unique STAT heterodimers by IL-21 provokes IL-1RI expression on CD8+ T cells, resulting in enhanced IL-1β dependent effector function", Immune Netw, 21, pp.e33~ (2021)
17. McMahan CJ, "A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types", EMBO J, 10, pp.2821~2832 (1991)
18. Weber A, "Interleukin-1(IL-1)pathway", Sci Signal, 3, pp.cm1~ (2010)
19. Casadio R, "Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta", IL-1R(I)complex, 2001, pp.499, 65~68
20. Fields JK, "Structural basis of IL-1 family cytokine signaling", Front Immunol, 10, pp.1412~ (2019)
21. Brikos C, "Mass spectrometric analysis of the endogenous type I interleukin-1(IL-1)receptor signaling complex formed after IL-1 binding identifies IL-1RAcP, MyD88, and IRAK-4 as the stable components", Mol Cell Proteomics, 6, pp.1551~1559 (2007)
22. Kawagoe T, "Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2", Nat Immunol, 9, pp.684~691 (2008)
23. Cao Z, "TRAF6 is a signal transducer for interleukin-1", Nature, 383, pp.443~446 (1996)
24. Wang D, "Structural insights into the assembly and activation of IL-1β with its receptors", Nat Immunol, 11, pp.905~911 (2010)
25. Colotta F, "Interleukin-1 type II receptor : a decoy target for IL-1 that is regulated by IL-4", Science, 261, pp.472~475 (1993)
26. Rauschmayr T, "Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation", Proc Natl Acad Sci U S A, 94, pp.5814~5819 (1997)
27. Tran DQ, "Selective expression of latency-associated peptide(LAP)and IL-1 receptor type I", II(CD121a, Blood, pp.2009, 113[DOI]
28. Ritvo PG, "Tfr cells lack IL-2Rα but express decoy IL-1R2 and IL-1Ra and suppress the IL-1-dependent activation of Tfh cells", Sci Immunol, 2, pp.eaan0368~ (2017)
29. Symons JA, "Soluble type II interleukin 1(IL-1)receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist", Proc Natl Acad Sci U S A, 92, pp.1714~1718 (1995)
30. Arend WP, "Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids", J Immunol, 153, pp.4766~4774 (1994)
31. Liu C, "Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA", J Biol Chem, 271, pp.20965~20972 (1996)
32. Vambutas A, "Alternate splicing of interleukin-1 receptor type II(IL1R2)in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED", PLoS One, 4, pp.e5293~ (2009)
33. Uchikawa S, "ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface", Cytokine, 71, pp.238~245 (2015)
34. Jouvenne P, "Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis : correlations with markers of inflammation and joint destruction", Arthritis Rheum, 41, pp.1083~1089 (1998)
35. Zheng Y, "Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation", Immunity, 38, pp.285~295 (2013)
36. Højen JF, "IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease", Nat Immunol, 20, pp.1138~1149 (2019)
37. Smith DE, "The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action", Immunity, 18, pp.87~96 (2003)
38. Eisenberg SP, "Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist", Nature, 343, pp.341~346 (1990)
39. Arend WP, "Interleukin-1 receptor antagonist : role in biology", Annu Rev Immunol, 16, pp.27~55 (1998)
40. Haskill S, "cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium", Proc Natl Acad Sci U S A, 88, pp.3681~3685 (1991)
41. Kwak A, "Intracellular interleukin(IL)-1 family cytokine processing enzyme", Arch Pharm Res, 39, pp.1556~1564 (2016)
42. Gabay C, "The human intracellular interleukin 1 receptor antagonist promoter appropriately regulates gene expression in keratinocytes and gastrointestinal epithelial cells in vivo", Cytokine, 11, pp.561~570 (1999)
43. Martin P, "Intracellular IL-1 receptor antagonist isoform 1 released from keratinocytes upon cell death acts as an inhibitor for the alarmin IL-1α", J Immunol, 204, pp.967~979 (2020)
44. Greenfeder SA, "Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex", J Biol Chem, 270, pp.13757~13765 (1995)
45. Schreuder H, "A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist", Nature, 386, pp.194~200 (1997)
46. Dinarello CA, "Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases", Nat Rev Drug Discov, 11, pp.633~652 (2012)
47. Ouyang W, "The biological functions of T helper 17 cell effector cytokines in inflammation", Immunity, 28, pp.454~467 (2008)
48. Chung Y, "Critical regulation of early Th17 cell differentiation by interleukin-1 signaling", Immunity, 30, pp.576~587 (2009)
49. Cho JS, "IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice", J Clin Invest, 120, pp.1762~1773 (2010)
50. Yasuda K, "The pathogenicity of Th17 cells in autoimmune diseases", Semin Immunopathol, 41, pp.283~297 (2019)
51. Lee HG, "Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis", Nat Commun, 10, pp.709~ (2019)
52. Akuzum B, "Context-dependent regulation of type17 Immunity by microbiota at the intestinal barrier", Immune Netw, 22, pp.e46~ (2022)
53. Boniface K, "Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2", EP4 receptor signaling, 2009, pp.206, 535~548
54. Sha Y, "Activated IL-1RI signaling pathway induces Th17 cell differentiation via interferon regulatory factor 4 signaling in patients with relapsing-remitting multiple sclerosis", Front Immunol, 7, pp.543~ (2016)
55. Huber M, "IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype", Proc Natl Acad Sci U S A, 105, pp.20846~20851 (2008)
56. Ikeda S, "Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-β-induced Foxp3 expression", J Immunol, 192, pp.1449~1458 (2014)
57. Zielinski CE, "Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β", Nature, 484, pp.514~518 (2012)
58. Duhen T, "IL-1β promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1", 17 cells that are specific for pathogenic and commensal microbes, 2014, pp.193, 120~129
59. Mufazalov IA, "IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells", EMBO J, 36, pp.102~115 (2017)
60. Joeckel LT, "Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice", J Virol, 86, pp.8713~8719 (2012)
61. Ichinohe T, "Inflammasome recognition of influenza virus is essential for adaptive immune responses", J Exp Med, 206, pp.79~87 (2009)
62. Ben-Sasson SZ, "IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells", J Exp Med, 210, pp.491~502 (2013)
63. Sarkar S, "Programming of CD8 T cell quantity and polyfunctionality by direct IL-1 signals", J Immunol, 201, pp.3641~3650 (2018)
64. Lapuente D, "IL-1β as mucosal vaccine adjuvant : the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses", Mucosal Immunol, 11, pp.1265~1278 (2018)
65. Van Den Eeckhout B, "Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant", NPJ Vaccines, 5, pp.64~ (2020)
66. Spolski R, "Interleukin-21 : a double-edged sword with therapeutic potential", Nat Rev Drug Discov, 13, pp.379~395 (2014)
67. Leonard WJ, "IL-21 signaling in immunity", F1000Res, 5, pp.F1000~ (2016)
68. Casey KA, "IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype", J Immunol, 178, pp.7640~7648 (2007)
69. Dinarello CA, "Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro", J Immunol, 139, pp.1902~1910 (1987)
70. Jayaraman P, "IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation", J Immunol, 190, pp.4196~4204 (2013)
71. Vasilyev FF, "Optimized flow cytometry protocol for analysis of surface expression of interleukin-1 receptor types I and II", Cytotechnology, 65, pp.795~802 (2013)
72. Penton-Rol G, "Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts", J Immunol, 162, pp.2931~2938 (1999)
73. van der Meer JW, "A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection", Proc Natl Acad Sci U S A, 85, pp.1620~1623 (1988)
74. He X, "TLR4-upregulated IL-1β and IL-1RI promote alveolar macrophage pyroptosis and lung inflammation through an autocrine mechanism", Sci Rep, 6, pp.31663~ (2016)
75. Cheng SC, "mTOR-and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity", Science, 345, pp.1250684~ (2014)
76. Arts RJW, "BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity", Cell Host Microbe, 23, pp.89~100 (2018)
77. Pang IK, "IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8+ T cell responses to influenza A virus", Nat Immunol, 14, pp.246~253 (2013)
78. Durrant DM, "IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis", J Exp Med, 210, pp.503~516 (2013)
79. Nikolouli E, "Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions", Cell Mol Immunol, 18, pp.182~193 (2021)
80. Mercer F, "Expression and function of TNF and IL-1 receptors on human regulatory T cells", PLoS One, 5, pp.e8639~ (2010)
81. De Simone M, "Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells", Immunity, 45, pp.1135~1147 (2016)
82. Plitas G, "Regulatory T cells exhibit distinct features in human breast cancer", Immunity, 45, pp.1122~1134 (2016)
83. Purvis HA, "Low-strength T-cell activation promotes Th17 responses", Blood, 116, pp.4829~4837 (2010)
84. Gagliani N, "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation", Nature, 523, pp.221~225 (2015)
85. Downs-Canner S, "Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells", Nat Commun, 8, pp.14649~ (2017)
86. Rudra D, "Transcription factor Foxp3 and its protein partners form a complex regulatory network", Nat Immunol, 13, pp.1010~1019 (2012)
87. Wu Y, "FOXP3 controls regulatory T cell function through cooperation with NFAT", Cell, 126, pp.375~387 (2006)
88. Clement RL, "Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses", Nat Immunol, 20, pp.1360~1371 (2019)
89. Pou J, "Type II interleukin-1 receptor expression is reduced in monocytes", macrophages and atherosclerotic lesions, 2011, pp.1811, 556~563
90. Colotta F, "Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes", J Immunol, 156, pp.2534~2541 (1996)
91. Kalliolias GD, "Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27", J Immunol, 185, pp.7047~7056 (2010)
92. Mantovani A, "Macrophage polarization : tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes", Trends Immunol, 23, pp.549~555 (2002)
93. Shimizu K, "IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages", J Immunol, 194, pp.3156~3168 (2015)
94. Martin P, "Mouse neutrophils express the decoy type 2 interleukin-1 receptor(IL-1R2)constitutively and in acute inflammatory conditions", J Leukoc Biol, 94, pp.791~802 (2013)
95. Sun B, "Characterization and allergic role of IL-33-induced neutrophil polarization", Cell Mol Immunol, 15, pp.782~793 (2018)
96. Luís JP, "The therapeutic prospects of targeting IL-1R1 for the modulation of neuroinflammation in central nervous system disorders", Int J Mol Sci, 23, pp.1731~ (2022)
97. Schlüter T, "Regulation of IL-1 signaling by the decoy receptor IL-1R2", J Mol Med(Berl), 96, pp.983~992 (2018)
98. Economides AN, "Cytokine traps : multi-component, high-affinity blockers of cytokine action", Nat Med, 9, pp.47~52 (2003)
99. Terkeltaub RA, "Rilonacept in the treatment of acute gouty arthritis : a randomized, controlled clinical trial using indomethacin as the active comparator", Arthritis Res Ther, 15, pp.R25~ (2013)
100. Ridker PM, "Antiinflammatory therapy with canakinumab for atherosclerotic disease", N Engl J Med, 377, pp.1119~1131 (2017)
101. Hong DS, "MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers : an open-label, phase 1 dose-escalation and expansion study", Lancet Oncol, 15, pp.656~666 (2014)
102. Solomonidi N, "A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis", iScience, 26, pp.107670~ (2023)
103. Hou J, "Design of a superior cytokine antagonist for topical ophthalmic use", Proc Natl Acad Sci U S A, 110, pp.3913~3918 (2013)
104. Vigers GP, "X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1", J Biol Chem, 275, pp.36927~36933 (2000)
105. Quiniou C, "Development of a novel noncompetitive antagonist of IL-1 receptor", J Immunol, 180, pp.6977~6987 (2008)
106. Pinteaux E, "Cell-specific conditional deletion of interleukin-1(IL-1)ligands and its receptors : a new toolbox to study the role of IL-1 in health and disease", J Mol Med(Berl), 98, pp.923~930 (2020)

관련 논문AI추천